buserelin and its Impurities
Buserelin is approved for the treatment of hormone-responsive cancers including prostate cancer and premenopausal breast cancer, sex hormone-dependent uterine diseases including endometrial hyperplasia, endometriosis, and uterine fibroids, and in assisted reproduction for female infertility. Reference standards of Buserelin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
